MetaCap

ProKidney Statistics

NASDAQ: PROKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.04-0.02 (-1.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ProKidney by the numbers

ProKidney has a market capitalization of $415.2 million based on 209.63M shares outstanding. With trailing EPS of $-0.61, ProKidney is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.1% below its 50-day average and 40.3% below its 200-day average.

Average daily trading volume is 1.44M shares, or about $1.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PROK valuation vs. peer median

PROK compared with the median of 8 peer companies
MetricPROKPeer medianDifference
Market cap$415.21M$418.81M-1%
Avg. volume1.44M742.62K+93%

Peer median across 8 companies: TECX, TVGN, IRLA, CADL, FENC, RGNX, SANA, ALEC.

Valuation

Market cap
$415.21M
Price / sales (latest FY)
464.96
EPS (TTM)
$-0.61

Price and trading

Previous close
1.06
Open
1.03
Day range
1.02 – 1.08
52-week range
0.87 – 2.65
52-week change
-52.51%
Beta
—
Volume
1.90M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
415.21M
Forward Pe
-1.66
Eps
-0.61
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.65
Week52 Low
0.87
Avg Volume
1.44M
Shares Outstanding
209.63M
Ma50
1.45
Ma200
1.74
Earnings Date
Nov 12, 2026
Pct From52w High
-60.75%
Pct From52w Low
19.54%

Related